Analgesic Balm

Description

The product is a 1-ounce formulation of a topical analgesic balm. It is designed for external use to provide localized relief from pain. The balm's composition includes active ingredients that contribute to its analgesic properties, while the specific formulation ensures effective delivery to the affected area. The product is presented in a convenient size for easy application and portability.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. For children under 12 years of age, it is advised to consult a healthcare professional prior to use.

When administering the product, it is important to wash hands thoroughly with soap and water immediately after application, unless the treatment area involves the hands themselves. This practice helps to prevent unintended exposure and ensures proper hygiene.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that medical assistance be sought immediately if the product is swallowed. Additionally, users should discontinue use and consult a healthcare professional if any of the following occur: worsening of conditions or lack of improvement within 7 days, recurrence of symptoms after initial resolution within a few days, or development of excessive skin irritation.

Warnings and Precautions

For external use only. This product is contraindicated for application on wounds or any damaged, broken, or irritated skin. It should not be used on children under 12 years of age who present with arthritis-like conditions. The use of a heating pad in conjunction with this product is also prohibited.

Healthcare professionals should advise patients to consult a physician prior to use if there is any redness present over the affected area. During application, it is crucial to avoid contact with the eyes or mucous membranes, and patients should refrain from tightly bandaging the treated area.

In the event of ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are instructed to discontinue use and contact their healthcare provider if any of the following occur: the condition worsens or fails to improve within 7 days; symptoms resolve only to recur within a few days; or if excessive skin irritation develops.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for application on wounds or damaged, broken, or irritated skin. Additionally, the product should not be used on children under 12 years of age who have arthritis-like conditions, nor should it be used in conjunction with a heating pad. Patients are advised to consult a doctor prior to use if there is redness over the affected area.

While using this product, it is important to avoid contact with the eyes or mucous membranes, and to refrain from tightly bandaging the area of application.

Patients should discontinue use and seek medical advice if any of the following occur: the condition worsens or does not improve within 7 days; symptoms clear up and then recur within a few days; or if excessive skin irritation develops.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Analgesic Balm (menthol 10%, methyl salicylate 15%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age with arthritis-like conditions should not use this medication. It is essential for children in this age group to consult a healthcare professional prior to use to ensure safety and appropriateness of treatment.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There are no specific warnings, precautions, or contraindications regarding pregnancy associated with the use of GERI-CARE Analgesic Balm. Available data do not indicate any known risks to pregnant patients or potential adverse fetal outcomes. However, as with any medication, healthcare professionals should consider the benefits and risks when prescribing this product to women of childbearing potential. It is advisable for pregnant patients to consult their healthcare provider before using GERI-CARE Analgesic Balm to ensure it aligns with their individual health needs and circumstances.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, ensuring adequate ventilation, and monitoring vital signs.

If available, the use of antidotes or specific treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may provide additional guidance on the management of overdose cases.

Documentation of the incident, including the substance, amount ingested, and time of ingestion, is crucial for effective management and treatment planning.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Patients should be instructed to discontinue use and consult a doctor if any of the following occur: the condition worsens or does not improve within 7 days; symptoms resolve but then recur within a few days; or if excessive skin irritation develops. It is important for patients to be aware of these signs and to take appropriate action to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It should be stored at a controlled room temperature of 20º-25ºC (68º-77ºF) to ensure optimal stability and efficacy. Care should be taken to maintain these temperature conditions throughout the storage period.

Additional Clinical Information

Patients aged 12 years and older are advised to apply the medication to the affected area no more than 3 to 4 times daily. For children under 12 years of age, consultation with a doctor is recommended prior to use. Clinicians should counsel patients to wash their hands thoroughly with soap and water immediately after application, unless the treatment is for the hands. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Analgesic Balm, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)